Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Conley

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 10, 2008
Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victimsRobert K McNamara, Ronald Jandacek, Therese Rider, et al.
Archives of General Psychiatry|June 7, 2006
Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victimsYogesh Dwivedi, Amal C Mondal, Hooriyah S Rizavi, et al.
BMC Psychiatry|February 11, 2011
Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophreniaStephen J Ruberg, Lei Chen, Virginia Stauffer, et al.
Cost Effectiveness and Resource Allocation : C/E|April 9, 2009
Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United StatesNicolas M Furiak, Haya Ascher-Svanum, Robert W Klein, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophreniaDo-Un Jung, Young-Soo Seo, Jae-Hoon Park, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Fluoxetine augmentation of haloperidol in chronic schizophreniaJoo-Cheol Shim, Deanna L Kelly, Young-Hoon Kim, et al.
Journal of Medical Economics|February 7, 2012
Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United StatesHaya Ascher-Svanum, Nicolas M Furiak, Anthony H Lawson, et al.
Journal of Psychiatric Research|September 13, 2011
Proinflammatory cytokines in the prefrontal cortex of teenage suicide victimsGhanshyam N Pandey, Hooriyah S Rizavi, Xinguo Ren, et al.
Archives of General Psychiatry|March 8, 2003
Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjectsYogesh Dwivedi, Jagadeesh Sridhara Rao, Hooriyah S Rizavi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 8, 2007
Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjectsYogesh Dwivedi, Hooriyah S Rizavi, Tara Teppen, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 10, 2008
Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victimsRobert K McNamara, Ronald Jandacek, Therese Rider, et al.
Archives of General Psychiatry|June 7, 2006
Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victimsYogesh Dwivedi, Amal C Mondal, Hooriyah S Rizavi, et al.
BMC Psychiatry|February 11, 2011
Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophreniaStephen J Ruberg, Lei Chen, Virginia Stauffer, et al.
Cost Effectiveness and Resource Allocation : C/E|April 9, 2009
Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United StatesNicolas M Furiak, Haya Ascher-Svanum, Robert W Klein, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophreniaDo-Un Jung, Young-Soo Seo, Jae-Hoon Park, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Fluoxetine augmentation of haloperidol in chronic schizophreniaJoo-Cheol Shim, Deanna L Kelly, Young-Hoon Kim, et al.
Journal of Medical Economics|February 7, 2012
Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United StatesHaya Ascher-Svanum, Nicolas M Furiak, Anthony H Lawson, et al.
Journal of Psychiatric Research|September 13, 2011
Proinflammatory cytokines in the prefrontal cortex of teenage suicide victimsGhanshyam N Pandey, Hooriyah S Rizavi, Xinguo Ren, et al.
Archives of General Psychiatry|March 8, 2003
Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjectsYogesh Dwivedi, Jagadeesh Sridhara Rao, Hooriyah S Rizavi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 8, 2007
Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjectsYogesh Dwivedi, Hooriyah S Rizavi, Tara Teppen, et al.
Pageof 12